{
  "Cancer Histology Subtype (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2404, 
        2410
      ]
    }
  ], 
  "Cancer Histology Type (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2388, 
        2402
      ]
    }
  ], 
  "Final Diagnosis Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2286, 
        2313
      ]
    }
  ], 
  "Laterality (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2336, 
        2341
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2510, 
        2514
      ]
    }
  ], 
  "Macroscopic/Gross Description Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        748, 
        777
      ]
    }
  ], 
  "Microscopic Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2587, 
        2622
      ]
    }
  ], 
  "Nature of Specimen Heading (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2108, 
        2134
      ]
    }
  ], 
  "Negative Findings Phraseology (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2561, 
        2584
      ]
    }
  ], 
  "Neoplasm Grade-Score Name (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2439, 
        2452
      ]
    }
  ], 
  "Neoplasm Score Value (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2453, 
        2460
      ]
    }
  ], 
  "Organ/Body Structure (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2139, 
        2147
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2159, 
        2167
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2178, 
        2186
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2198, 
        2206
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2218, 
        2226
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2237, 
        2245
      ]
    }
  ], 
  "Relative Location (Ov)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2148, 
        2155
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2168, 
        2174
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2187, 
        2194
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2207, 
        2214
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2227, 
        2233
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2246, 
        2253
      ]
    }
  ], 
  "Specimen Identifier (At)": [
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2136, 
        2137
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2156, 
        2157
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2175, 
        2176
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2195, 
        2196
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2215, 
        2216
      ]
    }, 
    {
      "__agreement__": "TRUE POSITIVE", 
      "__annotator__": "Model - 20180202_CDC_B1B2B4_5,Model - 20180209_CDC_B1B2B4B5_6", 
      "__extent": [
        2234, 
        2235
      ]
    }
  ], 
  "__text": "MSH|^~\\&|PATHLAB_LIS|HOSPITAL 9^9999^MOH|PIMS|CCO|20160505091613|3E18C547BF5DED0B84DE9E9D925F997EA5ACD161|ORU^R01|99999999999999999999|P|2.5|\nPID|1||M999999999^^^^CMR^HOSPITAL&9999&MOH~M999999999^^^^^HOSPITAL&9999&MOH~M999999999^^^^MRN^HOSPITAL&9999&MOH~9999999999&KX&ON^^^^JHN||XXXXXXXXX^XXXXXXXX||99999999|M|||99 XXXXX XXXX^^XXXXXX^XX^X9X 9X9^999||9999999999^KX^OHIN|||||5775344558^KX^OHIN||||||||||||N|\nOBR|1||QCS1606564|11529-5^Surgical Pathology Study Report^LN^BX^Biopsy^L|||20160502100900|||73134^XXXXXXXX^XXXX^^^^XX||||20160502125835|Prostate RT Base&Prostate RT Mid&Prostate RT Apex&Prostate LT Base&Prostate LT Mid&Prostate LT Apex|999999^XXXXXXXX^XXXX^^^^XX||||N|20082009|20160505091613|||F|||||||99999^XXXXXX^XXXXX^^^^XX, XXXXX|\n\n\n\n\n\n\n\nPath report.gross description\n\n1. The specimen is received in a container of formalin labeled with the patient's name, whose initials are \"BD\", and \"sigmoid base\".\nNumber of fragments: 4\nDimensions: 0.1, 0.1, 1.2, 1.6 cm\nOther: nil\n1A - in toto\n2. The specimen is received in a container of formalin labeled with the patient's name, whose initials are \"BD\", and \"prostate right mid\".\nNumber of fragments: 3\nDimensions: 0.1, 1.2, 1.4 cm\nOther: nil\n2A - in toto\n3. The specimen is received in a container of formalin labeled with the patient's name, whose initials are \"B D.\", and \"prostate right apex\".\nNumber of fragments: 2\nDimensions: 1.5 and 1.7 cm\nOther: nil\n3A - in toto\n4. The specimen is received in a container of formalin labeled with the patient's name, whose initials are \"BD\", and \"prostate left base\".\nNumber of fragments: 4\nDimensions: 0.1, 0.3, 0.7, 1.5 cm\nOther: nil\n4A - in toto\n5. The specimen is received in a container of formalin labeled with the patient's name, whose initials are \"BD\", and \"prostate left mid\".\nNumber of fragments: 3\nDimensions: 0.1, 1.5-1.8 cm\nOther: nil\n5A - , in toto\n6. The specimen is received in a container of formalin labeled with the patient's name, whose initials are \"BD\", and \"prostate left apex\".\nNumber of fragments: 3\nDimensions: 0.1, 1.5, 1.7 cm\nOther: nil\n6A -in toto\nDP, HOSPITAL, 02/05/2016 2:12 PM\n\n\nPath report.site of origin\n\n1. Prostate RT Base\n2. Prostate RT Mid\n3. Prostate RT Apex\n4. Prostate LT Base\n5. Prostate LT Mid\n6. Prostate LT Apex\nClinical Information: PSA 9.9\n\n\nPath report.final diagnosis\n\n1-3. Prostate gland, right (base, mid and apex), core needle biopsies:\n- Adenocarcinoma (acinar, not otherwise specified)\n- Gleason grade 6 (3+3), ISUP Gleason Grade Group 1\n4-6. Prostate gland, left (base, mid and apex), core needle biopsies:\n- Negative for malignancy\n\n\nPath report.microscopic observation\n\nHistologic Type: Adenocarcinoma (acinar, not otherwise specified)\nSpecimen 1, Right base    Gleason grade: 6 (3+3), ISUP Gleason Grade Group 1\nNumber cores involved / total number cores: 1/2\nLinear percentage of prostate in each core involved by tumour: 7% in 2 foci, 0\nTotal linear percentage involved by tumour: 4%\nSpecimen 2, Right mid    Gleason grade: 6 (3+3), ISUP Gleason Grade Group 1\nNumber cores involved / total number cores: 2/2\nLinear percentage of prostate in each core involved by tumour: 50%, 50%\nTotal linear percentage involved by tumour: 50%\nSpecimen 3, Right apex    Gleason grade: 6 (3+3), ISUP Gleason Grade Group 1\nNumber cores involved / total number cores: 2/2\nLinear percentage of prostate in each core involved by tumour: 40% in 2 foci, 10%\nTotal linear percentage involved by tumour: 25%\nSpecimen 4-6, Left base, mid and apex: Negative for malignancy\nExtraprostatic fat invasion: Not identified\nSeminal vesicle invasion: Not identified\nPerineural invasion: Not identified\nLymphatic (small vessel) invasion: Not identified\nAdditional Pathologic Findings:\nImmunohistochemical staining with DPIN4 performed on selected cores shows an absence of a basal cell layer with strong cytoplasmic racemase staining consistent with the morphological impression of malignancy.\nIn accordance with the Quality Assurance Program in the Department of Pathology at the Queensway Carleton HOSPITAL, selected slides have been reviewed by a second pathologist, Dr. Z. Moloo, who agrees with the diagnosis of malignancy.\n\n\n"
}